Prostate Cancer Prostatic Dis 2020 Feb 28
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry.
Related Questions
Do prior treatments for mHSPC change your thinking on whether or not to use sipuleucel-T?
New answer by Medical Oncologist at Duke University School of Medicine (August 3, 2021)
I agree. Some of the factors I also use to optimally select patients most likely to have a substantial survival benefit with sip-T are PSA levels (lower levels associated with...